Barry Cukor

1.8k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

Barry Cukor is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Barry Cukor has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Barry Cukor's work include Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (2 papers) and Genetic factors in colorectal cancer (2 papers). Barry Cukor is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (2 papers) and Genetic factors in colorectal cancer (2 papers). Barry Cukor collaborates with scholars based in United States, Italy and India. Barry Cukor's co-authors include Massimo Loda, Michele Pagano, Philip T. Lavin, J. Milburn Jessup, Sun W. Tam, Blake Cady, Cristina Magi‐Galluzzi, Giulio Draetta, Molly Wanner and Peter J. Worland and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Gastrointestinal Endoscopy.

In The Last Decade

Barry Cukor

9 papers receiving 1.5k citations

Hit Papers

Increased proteasome-dependent degradation of the cyclin-... 1997 2026 2006 2016 1997 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Cukor United States 7 1.1k 943 229 227 198 9 1.6k
C Lu Japan 8 658 0.6× 1.0k 1.1× 270 1.2× 142 0.6× 167 0.8× 11 1.4k
Lydia Kriegl Germany 17 824 0.7× 617 0.7× 292 1.3× 254 1.1× 200 1.0× 22 1.3k
Shian‐Yang Peng Taiwan 13 540 0.5× 808 0.9× 418 1.8× 124 0.5× 165 0.8× 14 1.5k
Po‐Lin Lai Taiwan 20 548 0.5× 933 1.0× 485 2.1× 151 0.7× 205 1.0× 25 1.7k
S M Edgerton United States 13 1.1k 1.0× 748 0.8× 661 2.9× 262 1.2× 199 1.0× 14 1.7k
Werner Hilgers France 18 1.1k 1.0× 820 0.9× 557 2.4× 309 1.4× 234 1.2× 43 1.7k
Shao-Chun Chang United States 7 1.2k 1.0× 637 0.7× 349 1.5× 341 1.5× 448 2.3× 7 2.2k
Donata Vitagliano Italy 19 1.0k 0.9× 920 1.0× 228 1.0× 235 1.0× 390 2.0× 29 1.9k
Sabine Zumstein-Mecker Switzerland 9 544 0.5× 767 0.8× 174 0.8× 105 0.5× 394 2.0× 12 1.2k
Kang–Da Liu China 18 302 0.3× 600 0.6× 329 1.4× 148 0.7× 111 0.6× 41 1.2k

Countries citing papers authored by Barry Cukor

Since Specialization
Citations

This map shows the geographic impact of Barry Cukor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Cukor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Cukor more than expected).

Fields of papers citing papers by Barry Cukor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Cukor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Cukor. The network helps show where Barry Cukor may publish in the future.

Co-authorship network of co-authors of Barry Cukor

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Cukor. A scholar is included among the top collaborators of Barry Cukor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Cukor. Barry Cukor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cukor, Barry & Byron Cryer. (2008). The Risk of Re-Bleeding After An Index GI Bleed in Patients On Anticoagulation. Gastrointestinal Endoscopy. 67(5). AB243–AB243. 1 indexed citations
2.
Cangi, Maria Giulia, Barry Cukor, Sabina Signoretti, et al.. (2000). Role of the Cdc25A phosphatase in human breast cancer. Journal of Clinical Investigation. 106(6). 753–761. 186 indexed citations
3.
Altimari, Annalisa, Antonietta D’Errico, Barry Cukor, et al.. (2000). Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.. PubMed. 6(10). 3966–72. 64 indexed citations
4.
Cady, Blake, Molly Wanner, Peter J. Worland, et al.. (1997). The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.. PubMed. 57(7). 1259–63. 298 indexed citations
5.
Loda, Massimo, Barry Cukor, Sun W. Tam, et al.. (1997). Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Medicine. 3(2). 231–234. 910 indexed citations breakdown →
6.
Jessup, J. M., P T Lavin, Charles W. Andrews, et al.. (1995). Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Diseases of the Colon & Rectum. 38(12). 1257–1264. 22 indexed citations
7.
Nikulásson, Sigfús, Charles W. Andrews, Harvey Goldman, et al.. (1995). Sucrase-Isomaltase Expression in Dysplasia Associated With Barrett's Esophagus and Chronic Gastritis. International Journal of Surgical Pathology. 2(4). 281–286. 3 indexed citations
8.
Loda, Massimo, et al.. (1994). Nodular foci in parathyroid adenomas and hyperplasias: An immunohistochemical analysis of proliferative activity. Human Pathology. 25(10). 1050–1056. 42 indexed citations
9.
Loda, Massimo, Franz Fogt, Frank S. French, et al.. (1994). Androgen receptor immunohistochemistry on paraffin-embedded tissue.. PubMed. 7(3). 388–91. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026